David Barneda Ciurana
Member of the Research Line Cancer profiling
Email: david.barneda@umedicina.cat
ORCID: 0000-0002-4436-4100
David Barneda is a lecturer at the University of Vic – Central University of Catalonia (UVic-UCC). His research focuses on the cell biology of lipids in a range of biomedical contexts.
Among other studies, he has worked on the molecular mechanisms of lipid droplet growth and function in adipocytes and stem cells, as well as the roles of phospholipid metabolism and signalling in cancer and immune cells. This includes research on the mechanisms and functional roles underlying the intriguing acyl-chain specificity of phosphoinositides, carried out in the laboratory of Phill Hawkins and Len Stephens, pioneers of PI3K signalling.
David Barneda holds a BSc in Chemistry from the University of Girona and a BSc and PhD in Biochemistry and Molecular Biology from the Autonomous University of Barcelona (UAB). From 2011 to 2022 he was a postdoctoral researcher at Imperial College London, Queen Mary University of London, AstraZeneca and the Babraham Institute. In 2023, he joined the Faculty of Medicine at UVic-UCC, where he teaches Human Physiology in the Medicine and Odontology degrees.
My last happenings:
TR2Lab was present at the Spanish Society of Geriatric and Gerontological Nursing Congress
Recently, Dr. Marta Casals, member of TR2Lab, participated in the Congress of the Spanish Society of Geriatric and Gerontological Nursing (SEEGG), a leading scientific meeting for professionals dedicated to the care of older adults. As part of the scientific programme, Dr. Marta Casals presented an oral communication entitled “Translation, Cross-Cultural Adaptation and Validation of the Wound-QoL-17 Scale into Catalan.” The study aimed to provide a validated instrument for assessing the impact of chronic wounds on the quality of life of Catalan-speaking patients. The presentation described the translation and cultural adaptation process of the questionnaire, as well as the psychometric validation [...]
Molecular autopsy identifies the NaV1.5 p.Leu96Pro variant causing sodium current loss-of-function in unexplained sudden cardiac death
Authors: Albert Rigat Pujolasa, Rebecca Martínez-Moreno, David Carreras, Yajaira Alvarado-Cervantes, Elisabet Selga, Ramon Brugada, Guillermo J. Pérez, Fabiana S. Scornik Forensic Science International: Genetics, 86 (2027) 103587 DOI: 10.1016/j.fsigen.2026.103587 Read More Abstract Molecular autopsy can identify candidate variants in unexplained sudden cardiac death (SUD), but functional evidence is often required to support pathogenic interpretation and family risk assessment. Here, we investigated the functional consequences of the SCN5A c.287 T >C (NaV1.5_p.Leu96Pro) variant, identified in a 29-year-old man who died of SUD. Cascade screening identified additional relatives carrying the variant, with variable clinical expression. Sodium current (INa) was [...]
TR2Lab Joins Global Experts at the ERS International Congress 2026
Dr. Renata Da Palma, member of TR2Lab, participated in the ERS International Congress 2026 held in Barcelona, one of the world's largest and most influential meetings in respiratory medicine and science. During the event, she presented TR2Lab’s research on the anti-inflammatory effects of photobiomodulation therapy in an experimental model of asthma-COPD overlap. The congress brought together researchers, clinicians, and healthcare professionals from across the globe to share the latest advances in respiratory health, fostering scientific exchange and international collaboration. Scientific meetings such as ERS play an essential role in advancing research by facilitating knowledge sharing, promoting innovation, and creating new [...]
